Berkeley Capital Partners, LLC Astrazeneca PLC Transaction History

Berkeley Capital Partners, LLC

$330 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$55.72 - $67.12 $551,126 - $663,883	-9,891 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $29,602 - $34,978	-548 Reduced 5.25%	9,891 $576,000
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $9,000 - $9,847	-162 Reduced 1.53%	10,439 $627,000
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $49,388 - $61,383	1,020 Added 10.65%	10,601 $635,000
Q1 2021 May 04, 2021	BUY	$47.16 - $54.44 $282 - $326	6 Added 0.06%	9,581 $476,000
Q4 2020 Jan 28, 2021	SELL	$48.52 - $58.02 $9,461 - $11,313	-195 Reduced 2.0%	9,575 $479,000
Q3 2020 Nov 03, 2020	SELL	$53.07 - $61.1 $90,378 - $104,053	-1,703 Reduced 14.84%	9,770 $535,000
Q2 2020 Jul 30, 2020	SELL	$43.1 - $55.31 $246,876 - $316,815	-5,728 Reduced 33.3%	11,473 $607,000
Q1 2020 Apr 21, 2020	SELL	$37.79 - $51.33 $112,425 - $152,706	-2,975 Reduced 14.75%	17,201 $768,000
Q4 2019 Jan 24, 2020	SELL	$42.46 - $50.46 $31,377 - $37,289	-739 Reduced 3.53%	20,176 $1.01 Million
Q3 2019 Nov 01, 2019	SELL	$40.12 - $45.47 $29,006 - $32,874	-723 Reduced 3.34%	20,915 $932,000
Q2 2019 Aug 08, 2019	BUY	$37.28 - $41.68 $11,966 - $13,379	321 Added 1.51%	21,638 $893,000
Q1 2019 Apr 30, 2019	SELL	$35.49 - $43.02 $117,046 - $141,879	-3,298 Reduced 13.4%	21,317 $862,000
Q4 2018 Jan 28, 2019	SELL	$36.86 - $41.49 $82,787 - $93,186	-2,246 Reduced 8.36%	24,615 $935,000
Q3 2018 Oct 30, 2018	SELL	$34.76 - $39.72 $211,584 - $241,775	-6,087 Reduced 18.47%	26,861 $1.06 Million
Q2 2018 Aug 07, 2018	SELL	$34.55 - $37.05 $188,539 - $202,181	-5,457 Reduced 14.21%	32,948 $1.16 Million
Q1 2018 Apr 27, 2018	SELL	$32.97 - $36.63 $256,902 - $285,420	-7,792 Reduced 16.87%	38,405 $1.34 Million
Q4 2017 Feb 02, 2018	BUY	$32.09 - $34.78 $123,578 - $133,937	3,851 Added 9.09%	46,197 $1.6 Million
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $1.23 Million - $1.44 Million	42,346	42,346 $1.44 Million

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$5.04 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.31 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$3.15 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$2.85 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.37 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.

Account